{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:23:59Z","timestamp":1783563839384,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.euroneuro.2018.01.007","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T01:17:56Z","timestamp":1518743876000},"page":"341-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antidepressants as antipruritic agents: A review"],"prefix":"10.1016","volume":"28","author":[{"given":"Randeep","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.R.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2018.01.007_bib1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.1975.tb03148.x","article-title":"Skin manifestations associated with tumors of the brain","volume":"92","author":"Andreev","year":"1975","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-199902000-00005","article-title":"An open clinical trial of fluvoxamine treatment of psychogenic excoriation","volume":"19","author":"Arnold","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib4","series-title":"Goodman & Gilman's the Pharmacological Basis of Therapeutics","first-page":"429","article-title":"Drug therapy of depression and anxiety disorders","author":"Baldessarini","year":"2006"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0190-9622(81)70120-8","article-title":"Inhibition of histamine-induced pruritus by topical tricyclic antidepressants","volume":"5","author":"Bernstein","year":"1981","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.jaad.2005.05.040","article-title":"Severe chronic urticaria: response to mirtazapine","volume":"53","author":"Bigata","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000012386","article-title":"Paroxetine in a case of psychogenic pruritus and neurotic excoriations","volume":"69","author":"Biondi","year":"2000","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1176\/appi.psy.42.4.314","article-title":"Fluoxetine in pathologic skin picking","volume":"42","author":"Bloch","year":"2001","journal-title":"Psychosomatics"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00000542-199902000-00017","article-title":"Ondansetron is effective to treat spinal or epidural morphine-induced pruritus","volume":"90","author":"Borgeat","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib10","series-title":"Itch: Mechanisms and Management of Pruritus","first-page":"347","article-title":"The itches of HIV infection and AIDS","author":"Cockerall","year":"1994"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0885-3924(02)00645-0","article-title":"Mirtazapine for pruritus","volume":"25","author":"Davis","year":"2003","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-199605050-00007","article-title":"Mirtazapine: a review of its pharmacology and therapeutic potential in the management of major depression","volume":"5","author":"Davis","year":"1996","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaad.2006.04.025","article-title":"Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma","volume":"55","author":"Demierre","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0190-9622(99)70051-4","article-title":"Pharmacokinetics of doxepin in subjects with pruritic atopic dermatitis","volume":"41","author":"Drake","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.euroneuro.2018.01.007_bib15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0190-9622(94)70225-X","article-title":"Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group","volume":"31","author":"Drake","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib16","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/archderm.1995.01690240065010","article-title":"The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group","volume":"131","author":"Drake","year":"1995","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib17","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/ced.12851","article-title":"Delayed pressure urticaria treated with the selective serotonin reuptake inhibitor escitalopram","volume":"41","author":"Eskeland","year":"2016","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0091-6749(86)90232-0","article-title":"Efficacy of doxepin in the treatment of chronic idiopathic urticaria","volume":"78","author":"Goldsobel","year":"1986","journal-title":"J. Allergy. Clin. Immunol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0190-9622(85)70092-8","article-title":"Double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria","volume":"12","author":"Greene","year":"1985","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib20","first-page":"115","article-title":"Amitriptyline\/Ketamine as therapy for neuropathic pruritus and pain secondary to herpes zoster","volume":"14","author":"Griffin","year":"2015","journal-title":"J. Drugs Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1600-0625.2001.010002110.x","article-title":"Doxepin affects acetylcholine-induced cutaneous reactions in atopic eczema","volume":"10","author":"Groene","year":"2001","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib22","first-page":"386","article-title":"Fluoxetine is an effective treatment for neurotic excoriations: case report","volume":"51","author":"Gupta","year":"1993","journal-title":"Cutis"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1085-5629(05)80047-1","article-title":"Itch mediators","volume":"14","author":"Hagermark","year":"1995","journal-title":"Semin. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib24","first-page":"1","article-title":"Aprepitant for the treatment of chronic refractory pruritus","author":"He","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.euroneuro.2018.01.007_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaad.2004.01.045","article-title":"Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study","volume":"50","author":"Hundley","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib26","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/hep.510290450","article-title":"The pruritus of cholestasis","volume":"29","author":"Jones","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.7326\/0003-4819-97-2-222","article-title":"Unilateral neurogenic pruritus: paroxysmal itching associated with central nervous system lesions","volume":"97","author":"King","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib28","series-title":"Itch mechanisms and management of pruritus","first-page":"352","article-title":"Psychological and psychiatric aspects of itching","author":"Koblenzer","year":"1994"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib29","first-page":"31","article-title":"Oral mirtazapine in persistent chronic urticaria","volume":"42","author":"Kulac","year":"2008","journal-title":"Deri Hast. ve Frengi Arsivi"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib30","first-page":"2981","article-title":"Aquagenic pruritus from polycythemia vera--treatment with paroxetine, a selective serotonin reuptake inhibitor","volume":"170","author":"Kumler","year":"2008","journal-title":"Ugeskr. L\u00e6g."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2230.1991.tb00345.x","article-title":"Notalgia paraesthetica-report of three cases and their treatment","volume":"16","author":"Layton","year":"1991","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.clindermatol.2017.01.008","article-title":"Psychiatric disorders and pruritus","volume":"35","author":"Lee","year":"2017","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/bmjspcare-2014-000790","article-title":"Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse","volume":"6","author":"Lee","year":"2016","journal-title":"BMJ Support. Palliat. Care"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib34","series-title":"Itch: Mechanisms and Management of Pruritus","first-page":"23","article-title":"Chemical mediators of itching","author":"Lerner","year":"1994"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bmj.4.5937.165","article-title":"Letter: post-herpetic pruritus","volume":"4","author":"Liddell","year":"1974","journal-title":"Br. Med. J."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib36","first-page":"507","article-title":"Psychotropic drugs in dermatology","volume":"106","author":"Mart\u00edn","year":"2015","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/01.STR.15.5.901","article-title":"Unilateral neurogenic pruritus following a stroke","volume":"15","author":"Massey","year":"1984","journal-title":"Stroke"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib38","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0190-9622(84)70196-4","article-title":"Comparison of cinnarizine, cyproheptadine, doxepin, and hydroxyzine in treatment of idiopathic cold urticaria: usefulness of doxepin","volume":"11","author":"Neittaanmaki","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib39","first-page":"152","article-title":"Doxepin cream vs betamethasone cream for treatment of chronic skin lesions due to sulfur mustard","volume":"9","author":"Panahi","year":"2011","journal-title":"Skinmed."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.clindermatol.2011.11.013","article-title":"Use of psychotropic drugs in dermatology: unique perspectives of a dermatologist and a psychiatrist","volume":"31","author":"Park","year":"2013","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib41","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1517\/14656566.2010.484420","article-title":"Therapy of pruritus","volume":"11","author":"Patel","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/2013.jamadermatol.646","article-title":"Topical amitriptyline-ketamine for the treatment of brachioradial pruritus","volume":"149","author":"Poterucha","year":"2013","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jaad.2013.03.013","article-title":"Topical amitriptyline combined with topical ketamine for the management of recalcitrant localized pruritus: a retrospective pilot study","volume":"69","author":"Poterucha","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib44","first-page":"34","article-title":"Low-dose doxepin for treatment of pruritus in patients on hemodialysis","volume":"1","author":"Pour-Reza-Gholi","year":"2007","journal-title":"Iran. J. Kidney Dis."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clindermatol.2010.07.002","article-title":"Pruritus in the elderly","volume":"29","author":"Reich","year":"2011","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib46","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PSY.0b013e3181572799","article-title":"Psychiatric medications for the treatment of pruritus","volume":"69","author":"Shaw","year":"2007","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/bja\/aen241","article-title":"Prophylactic mirtazapine reduces intrathecal morphine-induced pruritus","volume":"101","author":"Sheen","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/15569520701212340","article-title":"Cetirizine, doxepin, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial","volume":"26","author":"Shohrati","year":"2007","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1540-9740.2007.05880.x","article-title":"Comparison of hydroxyzine and doxepin in treatment of pruritus due to sulfur mustard","volume":"6","author":"Shohrati","year":"2007","journal-title":"Skinmed."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib50","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4088\/JCP.v58n0802","article-title":"A double-blind trial of fluoxetine in pathologic skin picking","volume":"58","author":"Simeon","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib51","series-title":"Goodman & Gilman's the Pharmacological Basis of Therapeutics","first-page":"629","article-title":"Histamine, bradykinin and their antagonists","author":"Skidgel","year":"2006"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib52","first-page":"633","article-title":"Doxepin in the management of pruritus associated with allergic cutaneous reactions","volume":"31","author":"Smith","year":"1997","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2340\/00015555-0553","article-title":"Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labeled, two-arm proof-of-concept study","volume":"89","author":"Stander","year":"2009","journal-title":"Acta. Derm. Venereol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2340\/00015555-0305","article-title":"Clinical classification of itch: a position paper of the international forum for the study of itch","volume":"87","author":"St\u00e4nder","year":"2007","journal-title":"Acta Derm. Venereol."},{"issue":"1015-1016","key":"10.1016\/j.euroneuro.2018.01.007_bib55","first-page":"e1017","article-title":"Evaluation and management of a patient with chronic pruritus","volume":"130","author":"Steinhoff","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib56","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1176\/ajp.147.3.370a","article-title":"Fluoxetine for the treatment of compulsive facial picking","volume":"147","author":"Stout","year":"1990","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/qjmed\/hcg002","article-title":"Itch: scratching more than the surface","volume":"96","author":"Twycross","year":"2003","journal-title":"Q. J. Med."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib58","first-page":"257","article-title":"Paroxetine treatment of 3 cases of cholestatic pruritus due to gastrointestinal malignancy","volume":"107","author":"Unotoro","year":"2010","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib59","series-title":"Itch: Mechanisms and Treatment","first-page":"7","article-title":"Epidemiology of Itch","author":"Weisshaar","year":"2014"},{"key":"10.1016\/j.euroneuro.2018.01.007_bib60","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2340\/00015555-1400","article-title":"European guidelines on chronic pruritus","volume":"92","author":"Weisshaar","year":"2012","journal-title":"Acta. Derm. Venereol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib61","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1111\/ajd.12026","article-title":"Effective treatment of uremic pruritus and acquired perforating dermatosis with amitriptyline","volume":"55","author":"Yong","year":"2014","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib62","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMcp1208814","article-title":"Chronic pruritus","volume":"368","author":"Yosipovitch","year":"2013","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1529-8019.2008.00167.x","article-title":"Neuropathic and psychogenic itch","volume":"21","author":"Yosipovitch","year":"2008","journal-title":"Dermatol. Ther."},{"issue":"6","key":"10.1016\/j.euroneuro.2018.01.007_bib64","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.jpainsymman.2003.05.004","article-title":"Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial","volume":"26","author":"Zylicz","year":"2003","journal-title":"J. Pain. Symptom Manag."},{"key":"10.1016\/j.euroneuro.2018.01.007_bib65","first-page":"121","article-title":"Paroxetine for pruritus in advanced cancer","volume":"16","author":"Zylicz","year":"1998","journal-title":"J. Pain. Symptom Manag."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18300270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X18300270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T01:54:19Z","timestamp":1535075659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X18300270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0924977X18300270"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.01.007","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressants as antipruritic agents: A review","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2018.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}